G. Sloof

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

E. Steyerberg, A. Janssens, P. Fockens, 2011, Annals of Surgical Oncology.

OF THE STAGING PERFORMANCE OF 18 F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN ESOPHAGEAL CANCER

J. Pruim, M. Westerterp, H. Groen, 2018 .

Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer

R. Boellaard, O. Hoekstra, P. Fockens, 2008, Endoscopy.

University of Groningen Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET

E. Steyerberg, A. Janssens, P. Fockens, 2011 .

6 SYNCHRONOUS PRIMARY NEOPLASMS DETECTED ON POSITRON EMISSION TOMOGRAPHY IN STAGING OF PATIENTS WITH ESOPHAGEAL CANCER

T. Wiggers, E. Comans, M. Westerterp, 2018 .

Limited additional value of positron emission tomography in staging oesophageal cancer

P. Bossuyt, P. Fockens, E. Comans, 2007, The British journal of surgery.

University of Groningen Positron Emission Tomography in Staging of Esophageal Cancer

P. Fockens, J. Stoker, E. Comans, 2005 .

Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node.

G. Sloof, J. D. de Hullu, J. van der Velden, 2004, Gynecologic oncology.

Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.

H. Groen, P. Bossuyt, J. Pruim, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study.

R. Boellaard, P. Bossuyt, O. Hoekstra, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.